Drug Class or Subclass
Generic
Lamborexant
Brand Name
Dayvigo
| Interaction Color Code | Clinical Bottom Line | Clinical Effects | Drug 1 effect | Drug 2 dose | Drug 2 effect | Management | |
|---|---|---|---|---|---|---|---|
| Lenacapavir Lamborexant | Red: Avoid combination | Do not coadminister: potentially increased levels of lamborexant | Potential increased risk of excessive sedation |
Use alternative agents. |